Nature Communications study finds UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods Findings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impact Study defines sequencing, replication and process-control conditions […]
Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software update […]
Therapeutic and diagnostic developers gain flexibility, speed, and scalability to advance custom formulations from preclinical research to manufacturing for clinical trials, with a reviewed quote returned in under three business days HOLLISTER, Calif. — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, […]
Collaboration combines Tamarind Bio’s AI-powered molecular design platform with GenScript’s wet-lab capabilities to help researchers move from digital concepts to experimental proof PISCATAWAY, N.J. and SAN FRANCISCO — Artificial intelligence can now generate thousands of potential drug molecules in the time it once took to design one, dramatically expanding what scientists can imagine. Yet deciding […]
Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026 MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“PacBio”), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its Board of Directors has appointed Mark Van Oene as President and […]
FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies Paris, France — DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million […]
The phenol-free magnetic bead workflow includes DNase treatment to optimize cfRNA recovery for downstream sequencing and amplification IPSWICH, Mass. — New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit, which enables isolation of low-abundance, circulating cell-free RNA (cfRNA) and exome-associated RNA from biofluids including plasma, serum, urine and […]
BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS’s decentralized clinical trial assays and companion […]
Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]
Collaboration, coordinated through NCSTAR at QIMR Berghofer, gives Queensland researchers a pathway to trial and validate MGI’s integrated DCSP framework — spanning DNA genomics, cell omics, spatial omics and proteomics — locally, fast-tracking their translation into real-world research and future clinical applications. Brisbane, Australia — MGI Australia, the local Australia and New Zealand team of MGI Tech Co., Ltd. (MGI), […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
